Category: Kevin Outterson

Report urges controversial ‘delinkage’ to foster new antibiotics

April 9th, 2014 in 2014, Kevin Outterson, Nature, Newsmakers, School of Law 0 comments

Kevin-Outterson-260x300Nature
Kevin Outterson, School of Law

It is conceivable that the day may come when a pandemic bacterial strain emerges with resistance to all of the drugs currently available in our medical arsenal. Given this possible threat, a leading UK think tank has released a report calling for a radical new business model to kickstart the development of new antibiotics…

Expert quote:

“From society’s perspective, we want antibiotics to be available and used appropriately and from a company’s perspective, they want a credible commitment that when they commit funds to antibiotic research and development, in ten years’ time the money will be there.”

View full article

FDA to expedite drug OKs

February 22nd, 2014 in 2014, Boston Herald, Kevin Outterson, Newsmakers, School of Law 0 comments

Kevin-Outterson-260x300Boston Herald
Kevin Outterson, School of Law

The Food and Drug Administration wants to change the way it approves over-the-counter drugs, a move that could dramatically reduce the time it takes for thousands of products to reach store shelves…

Expert quote:

“The monograph system is a very clunky way to regulate thousands of products. It punishes companies that do ask to add or change an ingredient in their product by subjecting them to a process that can take years.”

View full article

The Search For New Antibiotics

February 17th, 2014 in 2014, Kevin Outterson, Newsmakers, NPR, School of Law 0 comments

Kevin-Outterson-260x300NPR “Here & Now”
Kevin Outterson, School of Law

Two drug companies, Roche Holding and GlaxoSmithKline, have announced they’ll ramp up research into antibiotics…

Listen to audio of expert Kevin Outterson

Political gridlock empowers US justices

June 30th, 2013 in 2013, Financial Times, Kevin Outterson, Newsmakers, School of Law 0 comments

outterson_white-new_65wFinancial Times (subscription required)
Kevin Outterson, School of Law

Antonin Scalia, the US Supreme Court’s most colourful conservative, issued a furious dissent from the bench on its ruling advancing gay rights this week, saying that his fellow justices had “an exalted notion” of their role in American democracy…

Expert quote:

“But in the current climate, what is the chance that Congress will be able to intervene? Virtually nil.”

View full article

Obama administration wants to loosen antibiotic approvals

June 10th, 2013 in 2013, Kevin Outterson, Minnesota Public Radio, Newsmakers, School of Law 0 comments

outterson_white-new_65wMinnesota Public Radio
Kevin Outterson, School of Law

What do you do when bugs are outwitting drugs? That’s the situation the medical community is facing with antibiotics…

Listen to audio

Budget Victim: Inspections For Compounding Pharmacies. Really?

May 20th, 2013 in 2013, Kevin Outterson, Newsmakers, School of Law, WBUR 0 comments

outterson_white-new_65wWBUR “CommonHealth”
Kevin Outterson, School of Law

Remember all that outrage last year when we learned that a Framingham compounding pharmacy, the New England Compounding Center, was at the heart of national meningitis outbreak?…

Expert quote:

“Fungal meningitis from improperly compounded products killed 55 people and infected more that 600.”

View full article

Woburn drug maker may stop making sterile injections

April 3rd, 2013 in 2013, Boston Globe, Kevin Outterson, Newsmakers, School of Law 0 comments

outterson_white-new_65wBoston Globe (subscription required)
Kevin Outterson, School of Law

The owner of a Woburn specialty pharmacy that recalled two dozen drugs after the discovery of ­unidentified contaminants told regulators Tuesday that he was uncertain whether he would continue mixing sterile injectable medications and eye solutions, the riskiest kind of compounded drugs…

View full article

For many doctors, drug-company work a windfall

March 17th, 2013 in 2013, Kevin Outterson, Lowell Sun, Newsmakers, School of Law 0 comments

outterson_white-new_65wLowell Sun
Kevin Outterson, School of Law

Dr. Andrew G. Kowal, an anesthesiologist at Lahey Hospital and Medical Center in Burlington, has earned $337,651 from Pfizer and Eli Lilly for speaking, consulting, meals and travel fees from 2009 to 2011…

Expert quote:

“We want the doctors to be making choices entirely based on medical evidence, knowing us and talking to patients. The idea they may be influenced by this type of funding is quite disturbing.”

View full article

Massachusetts Plans Stricter Control of Compounding Pharmacies

January 4th, 2013 in 2013, Kevin Outterson, New York Times, Newsmakers, School of Law 0 comments

outterson_white-new_65wNew York Times
Kevin Outterson, School of Law

New laws to strengthen state control of compounding pharmacies were proposed on Friday by Gov. Deval Patrick, in hopes of preventing another public health disaster like the current outbreak of meningitis caused by a contaminated drug made in Massachusetts…

View article

Fungal meningitis caused 37 needless deaths

December 26th, 2012 in 2012, Kevin Outterson, Newsmakers, School of Law, United Press International 0 comments

outterson_white-new_65wUnited Press International
Kevin Outterson, School of Law

The widow of the first patient who died from fungal meningitis due to contaminated steroid injections told a Washington hearing her nightmare will never end…

View article